Pharmacokinetic optimization of antiretroviral therapy in pregnancy.
about
Micronucleated erythrocytes in newborn rats exposed to raltegravir placental transfer.The association between HIV (treatment), pregnancy serum lipid concentrations and pregnancy outcomes: a systematic reviewImpact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy.Pharmacokinetics of tenofovir during pregnancy and postpartum.Basic obstetric pharmacology.Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients.Raltegravir in HIV-1-Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy.CYP3A4 polymorphism and lopinavir toxicity in an HIV-infected pregnant woman.Unexpected vertical transmission of HIV infection.Pharmacogenetics of pregnancy-induced changes in efavirenz pharmacokinetics.Evaluation of universal versus genotype-guided efavirenz dose reduction in pregnant women using population pharmacokinetic modelling.Simultaneous quantification of four antiretroviral drugs in breast milk samples from HIV-positive women by an ultra-high performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method.Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxisPhysiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective
P2860
Q33748099-EB41CF86-3CEF-4207-B317-12F3AAF90B18Q33893572-8AFDD840-AA02-4168-BD75-45ACCFAFB22AQ34710705-F5B3860A-7D8E-4C87-A48C-24B4D799059EQ36888597-BE8CFE55-37B8-4818-9B65-330A35F3A825Q38256590-79EEEB19-6343-4411-BFCB-9D1CB87D6965Q38954109-FC8E2F3C-1022-48E6-9D83-651BBACFFD71Q41257241-4A7FB40C-DF56-4181-81E6-5D6AD6550A5FQ41665599-FA33EA7B-EC27-4B8F-9B14-13934367054FQ42263864-7D6F54E8-516E-49A8-8DFC-667D3E016E75Q46158508-B57D5242-ECF7-4F8F-B300-FDDADB68344EQ46460183-CD7A9231-CFC2-4B20-B2EE-E71B76204996Q47551255-E42C217B-1215-406F-A552-604825B43C6EQ56910156-04A92444-2120-4836-9641-27B173F68E2FQ58073610-5A0657D8-3BCC-4909-B5AE-E85B3EE20D8E
P2860
Pharmacokinetic optimization of antiretroviral therapy in pregnancy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacokinetic optimization of antiretroviral therapy in pregnancy.
@en
type
label
Pharmacokinetic optimization of antiretroviral therapy in pregnancy.
@en
prefLabel
Pharmacokinetic optimization of antiretroviral therapy in pregnancy.
@en
P2860
P1476
Pharmacokinetic optimization of antiretroviral therapy in pregnancy
@en
P2093
Jennifer R King
Kajal Buckoreelall
P2860
P2888
P304
P356
10.1007/S40262-012-0002-0
P577
2012-10-01T00:00:00Z
P6179
1031638232